NSE · Healthcare · Drug Manufacturers - General
EPS came in at 1.78 against a street estimate of 2.63 — a miss of 32.3%.
with an average price target of ₹74.00.
| Document | Date |
|---|---|
| Investor presentation · Q1 FY27 KOPRAN LIMITED - Q1 FY2026-27 INVESTOR SUMMARY --- HEADLINE NUMBERS • Q1 FY2026-27 Revenue from Operations: Rs. 15,399 Lakhs (down from Rs. 23,402 | 2026-08-07 |
| Quarterly results · Q1 FY27 KOPRAN LIMITED - Q1 FY2027 FINANCIAL SUMMARY HEADLINE NUMBERS • Consolidated Revenue from Operations (Q1 FY27): Rs 15,399.43 lakhs vs Rs 13,521.62 l | 2026-08-07 |
| Annual report FY2026 | 2026-07-25 |
| Investor presentation KOPRAN LIMITED - FY 2025-26 INVESTOR SUMMARY HEADLINE NUMBERS • Revenue from Operations FY 2025-26: Rs. 68,142 lakhs (vs Rs. 63,359 lakhs FY 2024-25 | 2026-05-20 |
| Quarterly results · Q4 FY26 KOPRAN LIMITED – FINANCIAL SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Year ended March 31, 2026 (Standalone basis): - Revenue from Operations | 2026-05-19 |
| Quarterly results · Q3 FY26 KOPRAN LIMITED – Q3 FY2026 FINANCIAL SUMMARY HEADLINE NUMBERS Consolidated Results (Q3 ended December 31, 2025) • Revenue from Operations: Rs 19,427 | 2026-01-22 |
| Investor presentation · Q3 FY26 KOPRAN LIMITED - Q3 FY 2025-26 SUMMARY HEADLINE NUMBERS • Q3 FY 2025-26 Revenue from Operations: Rs. 19,428 lakhs (up 16.8% vs Q3 FY 2024-25: Rs. 16 | 2026-01-22 |
| Investor presentation · Q2 FY26 KOPRAN LIMITED – INVESTOR SUMMARY (HY FY 2025-26) HEADLINE NUMBERS • Half-Year Revenue (HY 2025-26): Rs. 25,313 lakhs, down 60% from Rs. 63,359 lakh | 2025-11-12 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹3 / share ex-date Aug 11, 2026 | 2026-08-11 |
| Dividend | ₹3 / share ex-date Sep 4, 2025 | 2025-09-04 |
| Announcement | Date |
|---|---|
| Scheme of Amalgamation approved by NCLT, newspaper publication notice Kopran Limited has published a newspaper notice as required by the National Company Law Tribunal (NCLT), Mumbai Bench, following an order dated April 9, 2026. This notice is being sent to co | 2026-05-04 |
| Amalgamation/Merger transaction announced Kopran Limited has informed the Exchange about Amalgamation/Merger | 2026-04-30 |
| Amalgamation/Merger announced Kopran Limited has informed the Exchange about Amalgamation/Merger | 2026-04-10 |
| Amalgamation/Merger announced Kopran Limited has informed the Exchange about Amalgamation/Merger | 2026-02-28 |
| Observation Letter received from BSE on Scheme of Amalgamation Kopran Limited has received an Observation Letter from the Bombay Stock Exchange (BSE) regarding a Scheme of Amalgamation. An Observation Letter is a procedural acknowledgment from the stock | 2026-02-27 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Kopran Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.